J. Lee

A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial☆

S.H. Park, D.H. Lim, Tae Sung Sohn et al. · Annals of Oncology · 2020 · 286 citations · Full text

Medicine, Oncology, Surgery +17

Phase I study of proteasome inhibitor bortezomib plus CHOP in patients with advanced, aggressive T-cell or NK/T-cell lymphoma

J. Lee, Cheolwon Suh, Hye Jin Kang et al. · Annals of Oncology · 2008 · 73 citations · Full text

Medicine, Hematology, Oncology +16

A randomized multi-center phase II trial of capecitabine (X) versus S-1 (S) as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer

Yoon‐Koo Kang, J. Lee, Yang Won Min et al. · Journal of Clinical Oncology · 2007 · 11 citations

Medicine, Oncology, Pharmacology +12